帕拉曼奈尔对减少焦点患者抑郁症的作用
Min Ming1, Long Chen2, Jian Huang3
1Department of Neurology, the First Affiliated Hospital of Gannan Medical University, China.
佩拉曼奈尔显著降低了焦点患者的抑郁症状,改善了焦点患者的生活质量. 控制也得到了改善,但没有观察到认知功能的显著变化.
科学领域:
- 神经学 神经学
- 临床精神病学 临床精神病学
背景情况:
- 抑郁症在患者中非常普遍.
- 焦点性往往与抑郁障碍同时发生.
研究的目的:
- 调查帕拉曼奈尔在缓解焦点患者抑郁症方面的疗效.
- 评估香对生活质量和控制的影响.
主要方法:
- 对68名焦点患者进行了前性观察性研究,这些患者接受了perampanel治疗.
- 使用贝克抑郁 inventory-II (BDI-II) 评估抑郁症,使用迷你精神状态检查 (MMSE) 评估认知功能,使用QOLIE-31评估生活质量.
- 在基线收集的数据,以及治疗开始后的6个月和12个月.
主要成果:
- 在12个月后,BDI-II分数显著下降,QOLIE-31分数有所改善.
- 观察到改善的控制,有32.1%无,73.2%在12个月后有反应.
- 在MMSE得分中没有显著变化;确定了影响佩拉曼奈尔抗抑郁作用的因素.
结论:
- 佩拉曼奈尔在减少焦点的抑郁症状方面表现出有效性.
- 这项研究表明,改善抑郁和控制发作之间存在正相关性.
- 限制包括没有对照组和小样本大小.
更多相关视频
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
Electroconvulsive Therapy
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
